Skip to Content


Paperwork Reduction Act; Notice of Intent To Collect; Comment Request

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Office of National Drug Control Policy.


The Office of National Drug Control Policy (ONDCP) seeks public comment on its proposed collection of information.


ONDCP proposes the extension of three existing data collection instruments used in the production of advertising for the National Youth Anti-Drug Media Campaign and for advertising tracking.

Purpose: The existing data collection instruments are critical to the continuity and improvement of the National Youth Anti-Drug Media Campaign.

Type and Title of Collections: Qualitative Research, OMB 3201-0011, uses focus groups. Copy Testing, OMB 3201-0006, consists of 15-minute online interviews. Tracking Study, OMB 3201-0010, consists of 15-minute online interviews.

Frequency: Qualitative Research and Copy Testing performed quarterly. Tracking Study performed weekly.

Affected Public: Teenagers and adult influencers of teenagers.

Estimated Burden: Qualitative Research, $19,800; Copy Testing, $16,500; Tracking Study, $37,700.

Additional information: Collection instruments similar to those proposed are available at the Information Collection Review section of​public/​jsp/​Utilities/​index.jsp.

Contact: Address comments or questions to Andrew Hertzberg through any of the following: Executive Office of the President, Office of National Drug Control Policy, Washington DC 20503;; (202) 395-6721 (fax); or, (202) 395-6353 (voice).

Start Signature

Signed in Washington DC on January 23, 2013.

Daniel R. Petersen,

Deputy General Counsel.

End Signature End Preamble

[FR Doc. 2013-01762 Filed 1-28-13; 8:45 am]